Objective To determine the incidence and occupational variation of granulosa cell tumours (GCTs) in Finland, Iceland, Norway and Sweden over a 60-year period, 1953-2012. Design A longitudinal cohort study.
Introduction
Granulosa cell tumours (GCTs) belong to the sex cordstromal group of ovarian tumours, and account for 3-5% of ovarian malignancies. 1, 2 They can be classified in juvenile and adult types, the latter representing 95% of GCTs. GCTs are usually diagnosed at an early stage, and have a favourable prognosis compared with the more common epithelial ovarian tumours. 3 The international incidence rate of GCT has varied between 0.47/100 000 and 1.6/ 100 000. [4] [5] [6] [7] Aetiological factors remain mostly unknown, although studies have found a somatic missense mutation in the FOXL2 gene in adult ovarian GCTs. 8, 9 In general, increased risk for ovarian cancer is associated with early age of menarche, late age of menopause, nulliparity, infertility, obesity and a family history of ovarian cancer. 10 High parity and use of oral contraceptives may reduce this risk. 11, 12 For GCTs specifically, nulliparity, infertility and obesity have been also suggested as possible risk factors, and parity and use of oral contraceptives as protective factors. 13, 14 There have been controversial reports on the effect of race. 6, 13 Sex cord-stromal tumours are not thought to have a hereditary component, although at least one case of adult GCT in first-degree relatives has been reported. 15 Occupation-related risks for ovarian cancer have seldom been studied. Evidence has shown a possible association between teaching occupations, 10 nursing, 16 occupations involving shift work, 17 exposure to silica dust, 18 and a risk for developing ovarian cancer. Increased risk for primary Fallopian tube cancer has been found among smelting workers, artistic workers, hairdressers, nurses, packers, shopworkers and clerical workers in the Nordic population. 19 To our knowledge, there are no previous studies on occupational risk factors for GCTs.
Finland, Iceland, Norway and Sweden have a combined population of about 20 million and approximately 1800 cases of ovarian cancer every year. 20 Each of the countries is characterized by a well-functioning health care system, as well as a nationwide population-based cancer registration system. 21 The object of this study is to evaluate the incidence of GCTs in the Nordic countries over several decades as well as among different occupations, using the comprehensive Nordic databases.
Materials and methods
The incidence data were based on the cancer registry data from each Nordic country except Denmark, due to restrictions in the coding systems. In Finland, the incidence rates were available from 1968, in Iceland from 1958, in Norway from 1953, and in Sweden from 1993, and were calculated for 5-year periods until 2012. For the Helsinki University Hospital (HUH) region in Finland, we cross-checked the cases for accuracy with the HUH pathology department. HUH region is responsible for the cancer treatment of 1.9 million inhabitants in Southern Finland. The incidence rates were calculated for age groups 20 years and older, and adjusted for age to the World Standard population (truncated to age categories 20+). For Iceland, a 15-year floating average in total incidence was calculated due to the small number of cases. We used quasi-Poisson regression models to test the significance of difference between the categories.
The The relative level of the cancer incidence of the occupational category was described using the standardised incidence ratio (SIR), with the cancer incidence rates for the entire national study populations as a reference rate. For each country and occupational category, the observed number of cancer cases and person years were stratified into 5-year age categories and 5-year calendar periods. For each SIR, a 95% confidence interval (CI) was defined assuming a Poisson distribution for the observed number of cases. The ethics committee of Helsinki University Hospital and the National Supervisory Authority for Welfare and Health approved the study.
Results
The incidence rates of GCT were quite stable over the years, and remained around 0.6-0.8 per 100 000 for most of the study period ( Figure 1 ). There was no clearly increasing or decreasing trend in incidence of GCT in any country. In 1993-2012, the overall incidence was significantly higher in Finland than in Norway (RR 1.38) or Sweden (RR 1.49, Table S1 ). The incidence was highest between 50 and 64 years of age. The age peak was sharper in Finland and Norway than in Sweden in 1993-2012 (Figure 2) . In 1993-2002, the Nordic incidence peaked at 55-64 years, whereas in 2003-2012 the peak was less abrupt and reached 70-74 years ( Figure S1 ).
In the occupational cohort, 776 GCT cases in all were detected: 195 in Finland, seven in Iceland, 341 in Norway, and 233 in Sweden. The SIR was highest among welders (3.78, 95% confidence interval (CI) 0.10-21.1), dentists (3.65, 0.75-10.7), forestry workers (3.35, 0.08-18.7), transport workers (3.15, 0.65-9.20) and printers (2.11, 0.69-4.92), but none of the SIRs was statistically significant ( Table 1 ). The SIR was significantly decreased among teachers (0.64, 0.38-0.99). The only significantly increased period-specific SIR was observed among building caretakers in 1991-2005 (1.51, 1.01-2.17). Printers had a significantly elevated SIR at 30-49 years of age (6.40, 1.74-16.4), transport workers and building caretakers at 50-69 years of age (5.55, 1.14-16.2), and packers at the age of 70 years or older (3.25, 1.06-7.59) ( Table 2 ).
Discussion

Main findings
The incidence rates of GCT remained quite stable during the study period of 1958-2012, when there was a slightly increasing cancer incidence overall. 22 The incidence was highest between 50 and 64 years of age. In the occupational cohort, no occupations with a clearly elevated risk for GCT were observed.
Strengths and limitations
To our knowledge, this is the first study to combine GCT incidence data from several countries and over many decades. We also present the first study on occupational risk factors for GCT. The strengths of this study are the reliable and comprehensive Nordic cancer registry incidence data, and the long observation period of up to 60 years. A limitation is that, considering the retrospective nature of the study, we did not have information on reproductive and lifestyle factors such as parity, infertility, smoking, body mass index (BMI) or use of hormonal therapy,which may contribute to the risk of developing GCTs. We recognise the possibility of missing cases and the difficulty of ascertaining GCT coding accuracy in registry data. The occupational analyses suffer from low power, and the confidence intervals were wide, even without corrections for multiple comparisons.
Interpretation
The incidence rates of GCT in our study remained mostly in the lower end of reported international incidence rates -especially considering that the truncation of the age categories increases the numerical value of the rate compared with the rates that also include the youngest age categories with virtually zero incidence, as is the case with adult-type GCT. Comparison with previous studies is, however, somewhat difficult, as it is unclear how the earlier incidence rates were obtained. It seems that the incidence of GCT has remained quite constant over decades, and did not reveal clearly increasing or decreasing trends in any of the countries included in the study, even though remarkable changes in lifestyle and reproductive behaviour have taken place over the study period. Between 1970 and 2004, the fertility rate has decreased in all of the countries by CI, confidence interval; SIR, standardized incidence ratio. Occupations with < 3 observed cases are excluded.
2-38%, 21 and use of hormonal therapies such as oral contraceptives and postmenopausal hormonal therapies both increased and then decreased. 4, 23 However, the incidence in Finland was somewhat higher than in the other Nordic countries, and also varied more. An earlier Finnish study suggested that the decrease in the GCT incidence after 1970s, also seen in our data, might be associated with increased use of oral contraceptives or changes in both diagnostic methods and criteria. 4 This is unlikely, as the incidence in Finland increased again in the 1990s. Furthermore, there is no reason to believe that these factors would have developed differently in Finland than in other Nordic countries. The use of postmenopausal hormone therapy increased from the 1970s until the 1990s in all Nordic countries, but decreased by up to 61% in 1999-2005. 23 However, the decrease in Finland was remarkably less (25%) than in other Nordic countries, 23 so this can hardly explain the variation in the Finnish data.
A possible explanation for varying incidence rates between time periods and regions is the diversity in both diagnostic and registry accuracy over time. The histology of GCT is complex and the diagnosis is known to be demanding. 3, 24 These tumours include several histological subtypes, and the differential diagnosis between, for example, thecomas, endometrioid carcinomas and hypercalcaemic small cell carcinomas can be difficult. 3 Also, the malignancy of GCT has not always been recognised. The ICD morphology codes 8620/1 and 8621/1 are non-malignant, even though they represent ovarian granulosa cell tumours. Reporting of non-malignant neoplasms by clinicians may have been less complete than reporting of malignant ones, especially in past decades. Therefore, any reports on the incidence rate of GCTs should be interpreted with caution.
Many studies have shown that the incidence of GCT is highest at perimenopause or early postmenopause. [1] [2] [3] 24, 25 The observations in our series show a high incidence also in the 55-74 years age group, i.e. in late postmenopause. This is consistent with the hypergonadotropic state after menopause, which is also associated with many other gynaecological malignancies. 26 GCTs before the age of 35 are extremely rare. The incidence peak in the peri-and postmenopausal age group seems to have somewhat smoothed in the most recent time period, and was also lower in Sweden than in Finland and Norway. The reason for this remains unclear.
Not single occupation was associated with a significantly increased risk for GCT, and the only significantly decreased risk was found among teachers. A previous Canadian study found an elevated risk for teaching occupations and epithelial ovarian cancer, 10 whereas the large NOCCA study reported practically no specific risk for ovarian cancer among teachers. 21 In our study, the highest SIR (3.65) was seen among dentists. The mean age at first birth among highly educated women is higher and the total number of pregnancies smaller than in lower socio-economic classes, 21 which increases the risk of ovarian cancer and may also affect the risk of GCT.
We also observed increased SIRs among building caretakers, printers, transport workers and packers, but only in specific age categories. A previous Swedish study reported an elevated risk for ovarian cancer among packaging workers, and the NOCCA-study also found this among printers, possibly related to chemical exposure. 21, 27 Waiters, who in the past were exposed to cigarette smoke, showed a decreased risk for GCT, although this was non-significant.
Boyce et al. 13 have suggested the use of oral contraceptives, smoking and high parity as protective factors, and non-white race and obesity as risk factors in a study with 72 U.S. women with GCT. These risk factors were suggested to represent a hyperoestrogenic state associated with the development of GCT. A recent study on young Swedish women with 53 sex cord-stromal tumours (SCSTs) provided some evidence linking preterm birth with increased risk of SCSTs, but this study was likely to include mainly juvenile GCTs considering the low median age (21.2 years) at diagnosis. 28 Another European study suggested that elevated serum androgens during early pregnancy play a role in the later pathogenesis of SCSTs. 29 Stronger evidence for the hormonal aetiology of these tumours has yet to be shown.
Conclusion
The incidence of GCT has remained quite stable over time and there are no remarkable differences in the incidence among the four Nordic countries included in the study. Although some previous evidence suggests a possible hormonal role in the development of GCT, major changes in the use of oral contraceptives, postmenopausal hormonal therapy, fertility rate and lifestyle in general during the study period do not appear to have affected the incidence of GCT in our study. As no clear occupational risks were evident in the data, our findings support the concept of GCT as a primarily sporadic, not an exposure-related, cancer. In future investigations, an epidemiological case-control analysis focusing on the use of oral contraceptives and postmenopausal hormonal therapy among GCT patients would be of great interest.
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